Immune Design Corp.
Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids

Abstract:

The present disclosure relates generally to gene delivery using a chimeric, retroviral-RNA replicon vector particle for increased expression of transgenes in a host cell. In particular, the chimeric vectors described herein can be used in any of a variety of settings including gene therapy and vaccine settings.